top of page

The CEO of Marengo Therapeutics talks about his company's focus on activating and expanding T-cells

Zhen Su gives an overview Marengo, shares his view of #SITC23, and describes SITC's new biotech initiative with its goal of 100 new approved medicines over the next decade.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page